4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-25-025282
CEO and CFO bought 4,600 shares at $8.37 ($38,502)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2025-11-25 | Purchase | +4,600 | $8.37 | $38,502 | 5,588,102 | D |
| Open-market purchases · 4,600 sh · avg $8.37 · $38,502 | |||||||
Loading xslF345X05/ownership.xml…